These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 1777898

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunologic monitoring with Orthoclone OKT3 therapy.
    Schroeder TJ, First MR, Hurtubise PE, Marmer DJ, Martin DM, Mansour ME, Melvin DB.
    J Heart Transplant; 1989; 8(5):371-80. PubMed ID: 2529358
    [Abstract] [Full Text] [Related]

  • 4. OKT3 treatment for steroid-resistant acute rejection in kidney transplantation.
    Sevmis S, Emiroglu R, Karakayali F, Yagmurdur MC, Dalgic A, Moray G, Haberal M.
    Transplant Proc; 2005 Sep; 37(7):3016-8. PubMed ID: 16213290
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
    Cantarovich M, Latter DA, Loertscher R.
    Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prophylactic use of OKT3 in immunologic high-risk cadaver renal transplant recipients.
    Schroeder TJ, First MR, Mansour ME, Alexander JW, Penn I.
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):14-8. PubMed ID: 2510506
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. OKT3 for the treatment of steroid-resistant acute renal allograft rejection.
    Jogose JT, Bailey RR, Lynn KL, Robson RA, Wells JE.
    Nephron; 1997 Nov; 77(3):298-303. PubMed ID: 9375823
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. How successful is OKT3 rescue therapy for steroid-resistant acute rejection episodes after heart transplantation?
    Wagner FM, Reichenspurner H, Uberfuhr P, Kur F, Kaulbach HG, Meiser BM, Ziegler U, Reichart B.
    J Heart Lung Transplant; 1994 Nov; 13(3):438-42; discussion 442-3. PubMed ID: 8061020
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Successful infliximab treatment of steroid and OKT3 refractory acute cellular rejection in two patients after intestinal transplantation.
    Pascher A, Radke C, Dignass A, Schulz RJ, Veltzke-Schlieker W, Adler A, Sauer IM, Platz K, Klupp J, Volk HD, Neuhaus P, Mueller AR.
    Transplantation; 2003 Aug 15; 76(3):615-8. PubMed ID: 12923454
    [Abstract] [Full Text] [Related]

  • 18. Clinical experience with Muromonab-CD3 monoclonal antibody (OKT3) in heart transplantation.
    Macris MP, Frazier OH, Lammermeier D, Radovancevic B, Duncan JM.
    J Heart Transplant; 1989 Aug 15; 8(4):281-7. PubMed ID: 2504894
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.